Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Biochimica Et Biophysica Acta|May 12, 1988
Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerizationW Ruf, A Bender, D A Lane, et al.
The Journal of Biological Chemistry|August 5, 1990
Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory propertiesH J Ehrlich, R K Gebbink, J Keijer, et al.
The Journal of Experimental Medicine|January 20, 1997
Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alphaH Neumann, H Schmidt, A Cavalié, et al.
European Journal of Biochemistry|November 6, 1989
Sulfation of two tyrosine-residues in human complement S-protein (vitronectin)D Jenne, A Hille, K K Stanley, et al.
Biochemical and Biophysical Research Communications|December 16, 1987
Structural homology of human complement component C8 gamma and plasma protein HC: identity of the cysteine bond patternJ A Haefliger, D Jenne, K K Stanley, et al.
Thrombosis and Haemostasis|May 24, 2000
Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix FS L Schousboe, R Egelund, T Kirkegaard, et al.
European Journal of Biochemistry|June 15, 1991
Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin IIIT Koyama, J F Parkinson, P Sié, et al.
Blood|August 15, 1994
Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membraneA Zanetti, G Conforti, S Hess, et al.
Thrombosis and Haemostasis|March 1, 1997
The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activatorM van Meijer, A Stoop, A Smilde, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1996
Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retinaH P Hammes, A Weiss, S Hess, et al.
Pageof 16